Imaging agents predict breast cancer response to endocrine therapy
Preclinical imaging of progesterone receptor signals usefulness of biomarker in determining effectiveness of therapy
2012-07-03
(Press-News.org) Reston, Va. (July 2, 2012) – Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage. Estrogen receptor-α (ERα) status is an important factor in determining the most appropriate treatment for breast cancer patients, especially for those who are ERα+ and likely to respond well to hormone-based, or endocrine, therapies.
Prominent professor and research chemist Michael J. Welch, PhD, who passed away in May, was a contributing author for this research. "Throughout his career, Dr. Welch specialized in the synthesis of new radiolabeled compounds for medical imaging, with a special emphasis on the growing numbers of applications in PET," said Dominique Delbeke, MD, PhD, editor of The Journal of Nuclear Medicine. Noted for his ability to see beyond the immediate aspects of basic work to potential future applications, Welch was both a prime mover and an integral part in the development of PET as it transitioned from a compelling investigative idea to widespread clinical acceptance. "Many of his discoveries and research will live on well into the future," said Delbeke.
The study, "Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer" was an example of his unique approach to research.
"Positron emission tomography, or PET, has typically been used to identify the target for endocrine therapy in breast cancer by demonstrating that ER is present in tumors using F-18-fluoroestradiol (FES)-PET, or by monitoring for hormone-induced changes in tumor metabolism—'metabolic flare'— with F-18-fluorodeoxyglucose (FDG)-PET once therapy has begun. What is novel about our study is that we chose to image progesterone receptor levels to see how the estrogen signaling pathway is functioning in response to endocrine therapy," said Amy Fowler, MD, PhD, lead author of the study.
In the study, mice with mammary cell lines (SSM1, SSM2 and SSM3) derived from STAT1-deficient mammary tumors—which are ERα+/PR+ and similar to the majority of human breast cancers—were imaged. Small-animal PET/computed tomography (CT) was performed using F-18-FES to image estrogen receptor status, F-18-fluoro furanyl norprogesterone (F-18-FFNP) for progesterone receptor status, and FDG for glucose uptake.
Initial imaging of the cell lines showed that SSM3 tumors displayed the greatest F-18-FES and F-18-FFNP uptake, and therefore, the SSM3 cell line was used to test the response to estradiol, an ER agonist, and fulvestrant, a pure ER antagonist. Upon treatment with estradiol, it was determined that PR expression is estrogen-inducible and indicative of ERα signaling in the SSM3 tumors. Mice treated with fulvestrant showed early decreases in F-18-FFNP uptake after initiation of therapy, prior to measurable growth inhibition. SSM2 tumors, which were not growth-inhibited by fulvestrant despite also being ERα+/PR+, showed no change in F-18-FFNP uptake after initiation of therapy. These data support the potential use of PR imaging with F-18-FFNP PET of patients with ERα+ breast cancer at baseline and shortly after initiation of endocrine therapy to distinguish between responders and nonresponders, and thus help facilitate the selection of therapies most appropriate for individual patients.
"An important goal of molecular imaging in cancer research is to noninvasively predict early responses to therapies in order to guide further management," noted Fowler. "Our work using a preclinical model of breast cancer helps support the notion that molecular imaging can achieve this goal by testing whether the target utilized for a specific therapy is not only present but also functional."
An estimated one in eight women will develop breast cancer in her lifetime. According to the American Cancer Society, an estimated 280,000 new cases of breast cancer were diagnosed among women in 2011, and nearly 40,000 died from the disease.
INFORMATION:
Authors of the article "Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer" include Amy M. Fowler, Terry L. Sharp, Nicole M. Fettig, Dong Zhou, Carmen S. Dence, and Michael J. Welch, Division of Radiological Sciences, Edward Mallinckrodt Institute of Radiology, St. Louis, Mo.; Szeman Ruby Chan and Robert D. Schreiber, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Mo.; and M. Jeyakumar, Kathryn E. Carlson and John A. Katzenellenbogen, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Ill.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-07-03
WACO, Texas (July 2, 2012) - Methamphetamine abuse leads to an increase in child abuse and neglect, which causes an increase in foster care admissions, according to a study from Baylor University.
The study, published online in the journal Economic Inquiry, found that a 1 percent increase in meth use led to a 1.5 percent increase in foster care admissions. It is the first study to provide evidence for meth abuse's causal effect on foster home admissions.
Follow this link to read the entire study: http://onlinelibrary.wiley.com/doi/10.1111/j.1465-7295.2012.00481.x/full
"Our ...
2012-07-03
(Boston) – A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise the possibility of using this type of combination therapy for different forms of breast cancer, including those that develop resistance to chemotherapy and other treatments.
The study was led by researchers at the Boston University Cancer Center. Sibaji Sarkar, PhD, adjunct instructor of medicine at BUSM, is the study's corresponding author. ...
2012-07-03
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie dormant for a time, only to later begin cloning, resulting in a return and metastasis of the disease.
One such type of cancer is called pediatric T cell acute lymphoblastic leukemia, or T-ALL, often found in children, who have few treatment options beyond chemotherapy.
A team of researchers – led by Catriona H. M. Jamieson, MD, PhD, associate professor ...
2012-07-03
Compared to the average three year life span of a common rat, the 10 to 30 year life of the naked mole rat, a subterranean rodent native to East Africa, is impressive. And compared to the human body, the body of this rodent shows little decline due to aging, maintaining high activity, bone health, reproductive capacity, and cognitive ability throughout its lifetime. Now a collaborative of researchers in Israel and the United States is working to uncover the secret to the small mammal's long — and active — lifespan.
Dr. Dorothee Huchon of Tel Aviv University's Department ...
2012-07-03
Every second, around 25 million cell divisions take place in our bodies. This process is driven by microtubule filaments which continually grow and shrink. A new study shows how so-called motor proteins in the cytosol can control their dynamics.
The cytoskeleton plays a central role in the process of cell division. It is composed in large part of protein filaments known as microtubules, which also help determine the size, shape and mobility of a cell. In a new study, LMU biophysicist Erwin Frey and his colleagues Anna Melbinger and Louis Reese have used a theoretical ...
2012-07-03
Heart attacks during pregnancy are uncommon, but the prevalence of heart disease in pregnant mothers has increased over the past decade as more women delay pregnancy until they are older. These women, who are generally less physically active than their younger peers, tend to have higher cholesterol levels and are at greater risk of heart disease and diabetes.
While research has shown that the heart typically functions better during pregnancy due to a rise in cardiac pumping capacity to meet increased demands, a new UCLA study in rats and mice demonstrates that heart ...
2012-07-03
WASHINGTON – Researchers have identified genetic markers that may influence whether a person finishes high school and goes on to college, according to a national longitudinal study of thousands of young Americans. The study is in the July issue of Developmental Psychology, a publication of the American Psychological Association.
"Being able to show that specific genes are related in any way to academic achievement is a big step forward in understanding the developmental pathways among young people," said the study's lead author, Kevin Beaver, PhD, a professor at the ...
2012-07-03
Women in countries with great gender inequality are more likely than men to support authoritarian values, according to a new study of 54 countries. The shift away from beliefs in independence and freedom is the result, social psychologists say, of authoritarianism helping such women cope with a threatening environment.
"If a person is authoritarian, they are more likely to follow what group leaders ask them to do, and to follow the crowd more generally," says Mark Brandt of DePaul University in Chicago, a co-author of the paper just published online in Personality and ...
2012-07-03
Shoes, cars, airplanes, rotor blades for wind turbines, self-adhesive notes, plasters – this is just a sample of the many products featuring adhesives. More than 820,000 tons of adhesive were produced in Germany in 2010, according to the German Adhesives Association – Industrieverband Klebstoffe. To this day the majority of adhesives are manufactured from petroleum-based materials. Only gradually is the industry also offering adhesives made from renewable raw materials such as starch, cellulose, dextrins, and proteins. Pioneering products featuring these new adhesives include ...
2012-07-03
CINCINNATI—Researchers at the University of Cincinnati (UC) Hoxworth Blood Center have discovered a new gene target for leukemia therapy.
These findings, slated for the July 26, 2012 print issue of Blood, the journal of the American Society of Hematology, could lead to cellular targets for a patient population that otherwise may not have desirable outcomes and could potentially stop the onset of leukemia before it begins.
A team led by Jose Cancelas, MD, PhD, an associate professor of pediatrics at the UC College of Medicine and director of the research division at ...
LAST 30 PRESS RELEASES:
[Press-News.org] Imaging agents predict breast cancer response to endocrine therapy
Preclinical imaging of progesterone receptor signals usefulness of biomarker in determining effectiveness of therapy
